John D. Lee

Array ( [id] => 6917676 [patent_doc_number] => 20050095237 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-05-05 [patent_title] => 'Methods of therapy and diagnosis using targeting of cells that express P2Y10' [patent_app_type] => utility [patent_app_number] => 10/648694 [patent_app_country] => US [patent_app_date] => 2003-08-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 28578 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 13 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0095/20050095237.pdf [firstpage_image] =>[orig_patent_app_number] => 10648694 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7230737 [patent_doc_number] => 20050079175 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-04-14 [patent_title] => 'Composition and methods for treatment asthma' [patent_app_type] => utility [patent_app_number] => 10/645913 [patent_app_country] => US [patent_app_date] => 2003-08-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 15 [patent_no_of_words] => 22381 [patent_no_of_claims] => 43 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0079/20050079175.pdf [firstpage_image] =>[orig_patent_app_number] => 10645913 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7166593 [patent_doc_number] => 20040077028 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-04-22 [patent_title] => 'Assay for thrombocytopenia associated with administration of platelet GPIIb-IIIa receptor antagonists' [patent_app_type] => new [patent_app_number] => 10/644434 [patent_app_country] => US [patent_app_date] => 2003-08-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 7758 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 122 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0077/20040077028.pdf [firstpage_image] =>[orig_patent_app_number] => 10644434 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7134697 [patent_doc_number] => 20040043419 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-03-04 [patent_title] => 'Javelinization of protein antigens to heat shock proteins' [patent_app_type] => new [patent_app_number] => 10/258147 [patent_app_country] => US [patent_app_date] => 2003-08-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 8324 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 41 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0043/20040043419.pdf [firstpage_image] =>[orig_patent_app_number] => 10258147 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7380077 [patent_doc_number] => 20040081649 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-04-29 [patent_title] => 'Treating Atopic dermatitis with IgE antagonists' [patent_app_type] => new [patent_app_number] => 10/640152 [patent_app_country] => US [patent_app_date] => 2003-08-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3653 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 19 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0081/20040081649.pdf [firstpage_image] =>[orig_patent_app_number] => 10640152 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7220178 [patent_doc_number] => 20040072222 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-04-15 [patent_title] => 'Peptide analogues of myelin basic protein epitopes in the treatment of experimental autoimmune encephalomyelitis (eae) and multiple sclerosis (ms)' [patent_app_type] => new [patent_app_number] => 10/467680 [patent_app_country] => US [patent_app_date] => 2003-08-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 5520 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 17 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0072/20040072222.pdf [firstpage_image] =>[orig_patent_app_number] => 10467680 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7395713 [patent_doc_number] => 20040022783 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-02-05 [patent_title] => 'Binding agents to CD23' [patent_app_type] => new [patent_app_number] => 10/632852 [patent_app_country] => US [patent_app_date] => 2003-08-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 8673 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 45 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0022/20040022783.pdf [firstpage_image] =>[orig_patent_app_number] => 10632852 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7388765 [patent_doc_number] => 20040030106 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-02-12 [patent_title] => 'Novel compounds and process' [patent_app_type] => new [patent_app_number] => 10/362527 [patent_app_country] => US [patent_app_date] => 2003-07-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 9101 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 9 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0030/20040030106.pdf [firstpage_image] =>[orig_patent_app_number] => 10362527 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7358064 [patent_doc_number] => 20040014063 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-01-22 [patent_title] => 'Il-6 detection for predicting risks of preterm delivery' [patent_app_type] => new [patent_app_number] => 10/276696 [patent_app_country] => US [patent_app_date] => 2003-07-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4419 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 24 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0014/20040014063.pdf [firstpage_image] =>[orig_patent_app_number] => 10276696 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 250540 [patent_doc_number] => 07582296 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2009-09-01 [patent_title] => 'Anti-idiotypic antibodies against factor VIII inhibitor and uses thereof' [patent_app_type] => utility [patent_app_number] => 10/523444 [patent_app_country] => US [patent_app_date] => 2003-07-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 12 [patent_no_of_words] => 12625 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 46 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/582/07582296.pdf [firstpage_image] =>[orig_patent_app_number] => 10523444 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7367254 [patent_doc_number] => 20040092446 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-05-13 [patent_title] => 'HA-1 epitopes and uses thereof' [patent_app_type] => new [patent_app_number] => 10/623176 [patent_app_country] => US [patent_app_date] => 2003-07-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 20 [patent_figures_cnt] => 20 [patent_no_of_words] => 29271 [patent_no_of_claims] => 48 [patent_no_of_ind_claims] => 17 [patent_words_short_claim] => 16 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0092/20040092446.pdf [firstpage_image] =>[orig_patent_app_number] => 10623176 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 322732 [patent_doc_number] => 07517965 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2009-04-14 [patent_title] => 'Non-neutralizing anti-aPC antibodies' [patent_app_type] => utility [patent_app_number] => 10/522086 [patent_app_country] => US [patent_app_date] => 2003-07-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 15790 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 48 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/517/07517965.pdf [firstpage_image] =>[orig_patent_app_number] => 10522086 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7291813 [patent_doc_number] => 20040110929 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-06-10 [patent_title] => 'TF binding compound' [patent_app_type] => new [patent_app_number] => 10/617619 [patent_app_country] => US [patent_app_date] => 2003-07-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 20809 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 39 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0110/20040110929.pdf [firstpage_image] =>[orig_patent_app_number] => 10617619 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7399429 [patent_doc_number] => 20040023307 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-02-05 [patent_title] => 'DNA encoding a novel RG1 polypeptide' [patent_app_type] => new [patent_app_number] => 10/616279 [patent_app_country] => US [patent_app_date] => 2003-07-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 22016 [patent_no_of_claims] => 43 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 72 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0023/20040023307.pdf [firstpage_image] =>[orig_patent_app_number] => 10616279 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7250083 [patent_doc_number] => 20050074410 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-04-07 [patent_title] => 'Methods for diagnosis of allergic bronchopulmonary aspergillosis' [patent_app_type] => utility [patent_app_number] => 10/612358 [patent_app_country] => US [patent_app_date] => 2003-07-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9081 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0074/20050074410.pdf [firstpage_image] =>[orig_patent_app_number] => 10612358 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 650748 [patent_doc_number] => 07112325 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2006-09-26 [patent_title] => 'Antibodies to calcium independent cytosolic phospholipase A2/B enzymes' [patent_app_type] => utility [patent_app_number] => 10/612668 [patent_app_country] => US [patent_app_date] => 2003-07-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 9137 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 139 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/112/07112325.pdf [firstpage_image] =>[orig_patent_app_number] => 10612668 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7004527 [patent_doc_number] => 20050169840 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-08-04 [patent_title] => 'Method for screening modulators of the immune system' [patent_app_type] => utility [patent_app_number] => 10/519090 [patent_app_country] => US [patent_app_date] => 2003-06-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3915 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0169/20050169840.pdf [firstpage_image] =>[orig_patent_app_number] => 10519090 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5711247 [patent_doc_number] => 20060052592 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-03-09 [patent_title] => 'Vaccines for suppressing ige-mediated allergic disease and methods for using the same' [patent_app_type] => utility [patent_app_number] => 10/518701 [patent_app_country] => US [patent_app_date] => 2003-06-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 6969 [patent_no_of_claims] => 31 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0052/20060052592.pdf [firstpage_image] =>[orig_patent_app_number] => 10518701 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7288636 [patent_doc_number] => 20040109858 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-06-10 [patent_title] => 'Conformation-specific anti-von Willebrand factor antibodies' [patent_app_type] => new [patent_app_number] => 10/465795 [patent_app_country] => US [patent_app_date] => 2003-06-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2620 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 16 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0109/20040109858.pdf [firstpage_image] =>[orig_patent_app_number] => 10465795 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 348534 [patent_doc_number] => 07494647 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2009-02-24 [patent_title] => 'Humanized antibody against human tissue factor (TF) and process of production of the humanized antibody' [patent_app_type] => utility [patent_app_number] => 10/462062 [patent_app_country] => US [patent_app_date] => 2003-06-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 35 [patent_figures_cnt] => 35 [patent_no_of_words] => 38533 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 28 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/494/07494647.pdf [firstpage_image] =>[orig_patent_app_number] => 10462062 [rel_patent_id] =>[rel_patent_doc_number] =>)